West Virginia Healthcare Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on West Virginia Healthcare Press.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on January 20, 2026

Jan. 20, 2026

WellSpan’s nationally-recognized MyWellSpan patient portal and application surpasses 1 million users

GlobeNewswire

Jan. 20, 2026

NAHQ and Joint Commission Launch Regulatory & Accreditation Micro-Credential to Advance Quality and Patient Safety

GlobeNewswire

Jan. 20, 2026

Vitalic Health, powered by HFMA, launches U.S. Healthcare Vitals Tracker to measure affordability, financial sustainability and health outcomes

GlobeNewswire

Jan. 20, 2026

Cosmos Health Announces Accelerating Customer Growth, Improving Unit Economics and Robotic Expansion Supporting $40M in Additional Annual Revenue

GlobeNewswire

Jan. 20, 2026

Orphai Therapeutics’ Phase 2a LAM-001 Study Selected for Oral Presentation at the American Thoracic Society (ATS) 2026 International Conference

GlobeNewswire

Jan. 20, 2026

MAIA Biotechnology Advances Ateganosine Cancer Treatment Program, Outlines Targeted 2026 Clinical Milestones and Growth Momentum

GlobeNewswire

Jan. 20, 2026

Rentschler Biopharma Announces Executive Board Changes and Next Phase of Corporate Strategy

GlobeNewswire

Jan. 20, 2026

AskLuci.io Releases Whitepaper Examining Hidden Administrative Work Costing Allied Health Clinics More Than Money

GlobeNewswire

Jan. 20, 2026

Comfort Keepers Ireland Highlights Urgent Need for Scaling Safe, Regulated Home Support

GlobeNewswire

Jan. 20, 2026

Adaptin Bio Advances Novel Brain Cancer Treatment Candidate Towards Phase 1 Glioblastoma Clinical Trial

GlobeNewswire

Jan. 20, 2026

First-of-its-kind Trojan Horse Cancer Treatment Approved for Clinical Trials

GlobeNewswire

Jan. 20, 2026

Methyl Cellulose Market worth $5.88 billion by 2030, at a CAGR of 10.0%, says MarketsandMarkets™

GlobeNewswire

Jan. 20, 2026

New National Report: Nurse-Led Coordination Strengthens Patient Access, Reduces Delays and Improves Throughput Across U.S. Health Systems

GlobeNewswire

Jan. 20, 2026

Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA Following FDA Review of HOPE-3 Topline Data

GlobeNewswire

Jan. 20, 2026

TOMI Environmental Solutions Secures UK CES contract integrating SteraMist iHP into Total Clean Air's Modular Cleanroom Platform

GlobeNewswire

Jan. 20, 2026

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Jan. 20, 2026

New Imprivata Survey Finds 85% of Healthcare IT Leaders Think Passwordless Authentication is Vital, but Adoption Lags Significantly

GlobeNewswire

Jan. 20, 2026

Interpace Biosciences Announces Preliminary 2025 Revenue, 2026 Revenue Guidance and Simplification of Capital Structure

GlobeNewswire

Jan. 20, 2026

SPARK NS and Haukeland University Hospital Announce Clinical Trial of D-Serine for Modifying Parkinson’s Disease Progression

GlobeNewswire

Jan. 20, 2026

BioAge Announces Indication Expansion for Oral NLRP3 Inhibitor BGE-102, with Plans to Initiate Phase 1b/2a Proof-of-Concept Clinical Trial in Patients with Diabetic Macular Edema in Mid-2026

GlobeNewswire